GRPEL2
GrpE protein homolog 2, mitochondrial
Also known as: DKFZp451C205, FLJ23713, GRPE2_HUMAN, Mt-GrpE#2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TAA5
- Gene
- GRPEL2
- Ensembl
- ENSG00000164284
- Chromosome
- 5
- Canonical length
- 225 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Predicted to enable adenyl-nucleotide exchange factor activity and unfolded protein binding activity. Predicted to be involved in protein import into mitochondrial matrix. Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
225 residues, UniProt reviewed canonical sequence.
>Q8TAA5|GRPEL2
1 MAVRSLWAGR LRVQRLLAWS AAWESKGWPL PFSTATQRTA GEDCRSEDPP DELGPPLAER
61 ALRVKAVKLE KEVQDLTVRY QRAIADCENI RRRTQRCVED AKIFGIQSFC KDLVEVADIL
121 EKTTECISEE SEPEDQKLTL EKVFRGLLLL EAKLKSVFAK HGLEKLTPIG DKYDPHEHEL
181 ICHVPAGVGV QPGTVALVRQ DGYKLHGRTI RLARVEVAVE SQRRLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRPEL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 43 nTPM
- vagina: 11 nTPM
- tonsil: 10 nTPM
- lung: 10 nTPM
- cervix: 9.6 nTPM
- heart muscle: 8.8 nTPM
Single-cell type
- esophageal apical cells: 1,370 nCPM
- late primary spermatocytes: 30 nCPM
- esophageal suprabasal cells: 26 nCPM
- extravillous trophoblasts: 23 nCPM
- lymphatic endothelial cells: 21 nCPM
- vascular endothelial cells: 20 nCPM
Immune cell
- T-reg: 15 nTPM
- basophil: 9.9 nTPM
- naive CD4 T-cell: 9.9 nTPM
- memory CD4 T-cell: 7.6 nTPM
- naive CD8 T-cell: 7.5 nTPM
- MAIT T-cell: 6.1 nTPM
Brain region
- cerebellum: 20 nTPM
- pons: 16 nTPM
- hypothalamus: 15 nTPM
- thalamus: 15 nTPM
- white matter: 14 nTPM
- midbrain: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.36
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- adenyl-nucleotide exchange factor activity
- protein homodimerization activity
- protein-folding chaperone binding
- unfolded protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRPEL2 as an antibody target. Whether an autoantibody or antibody against GRPEL2 could matter depends on whether native GRPEL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRPEL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GRPEL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...